Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
X4 Pharmaceuticals, Inc. - Common Stock
(NQ:
XFOR
)
3.869
-0.031 (-0.79%)
Streaming Delayed Price
Updated: 2:05 PM EST, Jan 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about X4 Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Oracle And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
↗
June 13, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. SunCar Technology Group Inc. (NASDAQ: SDA) shares jumped 31.2% to $22.13...
Via
Benzinga
Undervalued Stocks to Watch After X4 Pharma (NASDAQ:XFOR) News: KAVL, HNRC, AYRO, VVPR
May 18, 2023
Via
AB Newswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 17, 2023
Via
Benzinga
X4 Pharma Highlights 'Significant Reduction' Rate In Severity, Duration Of Infections
↗
May 17, 2023
X4 Pharmaceuticals Inc (NASDAQ: XFOR) highlighted new data from a Phase 3 clinical trial of once-daily, oral mavorixafor in
Via
Benzinga
What 5 Analyst Ratings Have To Say About X4 Pharmaceuticals
↗
May 05, 2023
Via
Benzinga
X4 Pharmaceuticals: Q1 Earnings Insights
↗
May 04, 2023
Via
Benzinga
A Preview Of X4 Pharmaceuticals's Earnings
↗
May 03, 2023
Via
Benzinga
A Preview Of X4 Pharmaceuticals's Earnings
↗
March 20, 2023
Via
Benzinga
X4 Pharmaceuticals: Q3 Earnings Insights
↗
November 03, 2022
X4 Pharmaceuticals (NASDAQ:XFOR) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:05 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For May 4, 2023
↗
May 04, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 12, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
March 28, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!
Via
InvestorPlace
Why Panbela Therapeutics Shares Are Trading Higher By Around 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
April 12, 2023
Gainers TESSCO Technologies Incorporated (NASDAQ: TESS) shares jumped 86.8% to $8.78 as it agreed to be acquired by entities affiliated with Lee Equity Partners and Twin Point Capital for $9.00 in...
Via
Benzinga
Earnings Scheduled For March 21, 2023
↗
March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million.
Via
Benzinga
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
↗
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
February 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
January 11, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
↗
December 22, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
December 19, 2022
On Monday, 297 companies reached new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
December 16, 2022
During Friday's trading, 293 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
↗
December 12, 2022
Via
Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
↗
December 07, 2022
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 07, 2022
Via
Benzinga
Why iBio Shares Are Trading Lower By Around 48%; Here Are 23 Stocks Moving Premarket
↗
December 07, 2022
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 71.3% to $0.7190 in pre-market trading after the company reported withdrawal of registration statement.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
December 07, 2022
It's time for another dive into the biggest pre-market stock movers as we check out the latest news traders need to know about on Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 30, 2022
Via
Benzinga
X4 Pharmaceuticals Shares Tumble After Phase 3 Data From Rare Immune Deficiency Candidate
↗
November 30, 2022
Via
Benzinga
Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session
↗
November 30, 2022
Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115.
Via
Benzinga
Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket
↗
November 30, 2022
Gainers Kalera Public Limited Company (NASDAQ: KAL) shares rose 33.3% to $0.2399 in pre-market trading after jumping 45% on Tuesday. Kalera recently announced restructuring process for German...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
November 29, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
